Emerald Health Pharmaceuticals has filed a Tier II Reg A+ preliminary prospectus seeking to raise $50 million by selling up to 10 million shares at $5 per share. The...

True Leaf Announces Initial Closing of its Regulation A+ Offering VERNON, British Columbia, Jan. 12, 2018 (GLOBE NEWSWIRE) — True Leaf Medicine International Ltd. (“True Leaf” or the “Company”)...

In order to help address the weak economic recovery and facilitate capital raising for small businesses, Congress approved the JOBS Act (Jumpstart Our Businesses) in 2011, which President Obama signed into...